1st-of-its-kind therapy blocks immune attack after stem-cell transplant Livescience.com
1st-of-its-kind therapy blocks immune attack after stem-cell transplant Livescience.com
Stem cell-based therapy for ALS deemed safe in Phase 2 study ALS News Today
The Stem Cell Renaissance: Innovations, Collaborations, and the... MedTech Outlook
Understanding Neuromyelitis Optica: Role of NF-B and Therapeutic Potential Medriva
Read the original post: Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS)
Read the original post: Celularity Releases CEO Letter to Shareholders
See the article here: PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
See the article here: Ikena Oncology Outlines Key Priorities and Provides Corporate Updates
Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors Investing.com Australia
Breakthrough in cancer research opening up stem cell therapy to more people. How you can get involved 69News WFMZ-TV
Recent Comments